BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21992909)

  • 1. Diabetic ketoacidosis with L-asparaginase therapy.
    Mondal R; Nandi M; Tiwari A; Chakravorti S
    Indian Pediatr; 2011 Sep; 48(9):735-6. PubMed ID: 21992909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transient diabetes mellitus with ketoacidosis in a child during the treatment of acute lymphoblastic leukemia with L-asparaginase].
    Skomra S; Przybylska T
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):31-2. PubMed ID: 1409032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic ketoacidosis secondary to L-asparaginase in acute lymphoblastic leukaemia.
    Gifford G; Milliken S; Greenfield J
    Intern Med J; 2013 Aug; 43(8):946-8. PubMed ID: 23919338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia.
    Cetin M; Yetgin S; Kara A; Tuncer AM; Günay M; Gümrük F; Gürgey A
    J Med; 1994; 25(3-4):219-29. PubMed ID: 7996065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia.
    Roberson JR; Raju S; Shelso J; Pui CH; Howard SC
    Pediatr Blood Cancer; 2008 Jun; 50(6):1207-12. PubMed ID: 18266226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL].
    Brodkiewicz A; Kamieńska E; Urasiński T; Peregud-Pogorzelski J
    Acta Haematol Pol; 1995; 26(1):99-101. PubMed ID: 7747569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase.
    Jameel PZ; Lohiya S; Dongre A; Damke S; Lakhkar BB
    BMC Pediatr; 2020 May; 20(1):228. PubMed ID: 32423425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retherapy using L-asparaginase with octreotide in a patient recovering from L-asparaginase-induced pancreatitis.
    Suzuki M; Takata O; Sakaguchi S; Fujimura J; Saito M; Shimizu T
    Exp Hematol; 2008 Mar; 36(3):253-4. PubMed ID: 18279714
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic ketoacidosis and persistent hyperglycemia as long-term complications of L-asparaginase-induced pancreatitis.
    Hsu YJ; Chen YC; Ho CL; Kao WY; Chao TY
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):441-5. PubMed ID: 12433031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
    Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
    Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetic ketoacidosis and hypofibrinogenemia as a complication of the treatment with L-asparaginase of acute lymphoblastic leukemia].
    López Herce Cid J; Martínez A; González M; García S
    Sangre (Barc); 1986; 31(2):195-9. PubMed ID: 3088740
    [No Abstract]   [Full Text] [Related]  

  • 13. Asparaginase-induced acute parotitis: an uncommon and self-limiting complication.
    Chan GC; Chiang AK; Ha SY; Lau YL; Ong JB; Lee AC
    Med Pediatr Oncol; 2002 Jul; 39(1):73-4. PubMed ID: 12116090
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy.
    Treepongkaruna S; Thongpak N; Pakakasama S; Pienvichit P; Sirachainan N; Hongeng S
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):812-5. PubMed ID: 19801948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia induced by chemotherapeutic agents used in acute lymphoblastic leukemia: report of three cases.
    Wang YJ; Chu HY; Shu SG; Chi CS
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):457-61. PubMed ID: 8281494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy.
    Charan VD; Desai N; Singh AP; Choudhry VP
    Indian Pediatr; 1993 Jun; 30(6):809-10. PubMed ID: 8132268
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase.
    Bodmer M; Sulz M; Stadlmann S; Droll A; Terracciano L; Krähenbühl S
    Digestion; 2006; 74(1):28-32. PubMed ID: 16988508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [L-asparaginase-induced hyperlipidemia in a case of acute lymphoblastic leukemia].
    Konya H; Tamura S; Miyazaki E; Inoue N; Okamoto T; Takemoto Y; Kohsaki M; Kanemaru A; Kakishita E
    Rinsho Ketsueki; 1991 Mar; 32(3):250-4. PubMed ID: 2041167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fulminant hepatitis possibly caused by L-asparaginase during induction chemotherapy in a patient with acute lymphoblastic leukemia].
    Tsutsui M; Koike M; Komatsu N
    Rinsho Ketsueki; 2012 May; 53(5):531-4. PubMed ID: 22728556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
    Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
    Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.